{"id":"7fd089c7-9bf9-5478-892c-71e0ffb4418d","stable_key":"a9dd23c6-978a-5755-8bd8-f29bd1fe0cda:nia-clin-kynu-human-low-nad","predicate":"associated_with_reduced","statement":"The cohort also included homozygous KYNU p.V57Efs*21 and compound-heterozygous p.Y156*/p.F349Kfs*4 patients with reduced circulating NAD and multiple malformations.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"cfe944dd-270e-5eaf-9c8c-36e37d22799a","mechanism_event_label":"KYNU is a second independent point where inherited failure can interrupt NAD production.","subject":{"id":"95c222be-9bc3-57ac-8a5b-6eb764301a32","slug":"kynu-biallelic-loss-of-function","display_name":"Biallelic KYNU loss-of-function genotype","entity_type_key":"gene"},"object":{"id":"6a1be942-8261-5ba7-9d98-2a50c0d51fc3","slug":"circulating-nad-content","display_name":"Circulating NAD content","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"cfe944dd-270e-5eaf-9c8c-36e37d22799a","stable_key":"a9dd23c6-978a-5755-8bd8-f29bd1fe0cda:nia-clin-kynu-human-low-nad-event","event_type":"observed_intervention","label":"KYNU is a second independent point where inherited failure can interrupt NAD production.","description":"The cohort also included homozygous KYNU p.V57Efs*21 and compound-heterozygous p.Y156*/p.F349Kfs*4 patients with reduced circulating NAD and multiple malformations.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"573bd034-6b1a-585e-9421-25ca28510d89","slug":"kynu","display_name":"Human kynureninase / KYNU","entity_type_key":"protein"},"role":"affected_enzyme","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"769339cb-213b-559e-acc0-07ed00368b94","slug":"l-tryptophan","display_name":"L-Tryptophan","entity_type_key":"small_molecule"},"role":"upstream_precursor","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"ed20e475-f13e-5118-9fce-e8cd6515c735","slug":"congenital-nad-deficiency-malformations","display_name":"Malformations in congenital NAD deficiency disorder","entity_type_key":"cellular_process"},"role":"observed_phenotype","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"95c222be-9bc3-57ac-8a5b-6eb764301a32","slug":"kynu-biallelic-loss-of-function","display_name":"Biallelic KYNU loss-of-function genotype","entity_type_key":"gene"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"6a1be942-8261-5ba7-9d98-2a50c0d51fc3","slug":"circulating-nad-content","display_name":"Circulating NAD content","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"cross_nutrient","value_text":"Human kynureninase / KYNU (affected_enzyme); L-Tryptophan (upstream_precursor); Malformations in congenital NAD deficiency disorder (observed_phenotype)","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/niacin-clinical-sources/shi2017.abstract.txt\", \"locator\": \"Indexed primary abstract\", \"file_sha256\": \"2c5dcc72d338ac41bd47e4363a149abc503859e2760398fed030f02d5891e2bb\", \"start_char\": 0, \"end_char\": 1874, \"text_sha256\": \"2c5dcc72d338ac41bd47e4363a149abc503859e2760398fed030f02d5891e2bb\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Four patients from unrelated families; sequencing and circulating metabolites, with parallel enzyme and mouse experiments","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Biallelic HAAO or KYNU loss-of-function variants","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Rare inherited synthesis impairment is distinct from dietary shortage. Prevention with gestational niacin was demonstrated in mice, not as an established prenatal treatment in humans.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Niacin research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"niacin","display_name":"Niacin (vitamin B3)","entity_type_key":"nutrient_element"}},{"dimension":"organism","value_text":"Homo sapiens","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"KYNU is a second independent point where inherited failure can interrupt NAD production.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[nia-clin-shi2017] NAD Deficiency, Congenital Malformations, and Niacin Supplementation. (2017). https://pubmed.ncbi.nlm.nih.gov/28792876/ DOI: 10.1056/nejmoa1616361","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Circulation and congenital organ development","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"9406ab80-7972-5256-8bba-215b496216a2","evidence_kind":"source_excerpt","locator":"Lines 1249-1261","start_line":1249,"end_line":1261,"excerpt":"### nia-clin-kynu-human-low-nad\nThe cohort also included homozygous KYNU p.V57Efs*21 and compound-heterozygous p.Y156*/p.F349Kfs*4 patients with reduced circulating NAD and multiple malformations.\nCondition category: machinery_impairment\nnutrient_topic: Niacin research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: KYNU is a second independent point where inherited failure can interrupt NAD production.\norganism: Homo sapiens\ntissue_or_cell_type: Circulation and congenital organ development\nexperimental_model: Four patients from unrelated families; sequencing and circulating metabolites, with parallel enzyme and mouse experiments\nlimitations: Rare inherited synthesis impairment is distinct from dietary shortage. Prevention with gestational niacin was demonstrated in mice, not as an established prenatal treatment in humans.\nexposure: Biallelic HAAO or KYNU loss-of-function variants\ncross_nutrient: Human kynureninase / KYNU (affected_enzyme); L-Tryptophan (upstream_precursor); Malformations in congenital NAD deficiency disorder (observed_phenotype)\nevidence_span: {\"source_cache\": \"artifacts/niacin-clinical-sources/shi2017.abstract.txt\", \"locator\": \"Indexed primary abstract\", \"file_sha256\": \"2c5dcc72d338ac41bd47e4363a149abc503859e2760398fed030f02d5891e2bb\", \"start_char\": 0, \"end_char\": 1874, \"text_sha256\": \"2c5dcc72d338ac41bd47e4363a149abc503859e2760398fed030f02d5891e2bb\"}\n[nia-clin-shi2017] NAD Deficiency, Congenital Malformations, and Niacin Supplementation. (2017). https://pubmed.ncbi.nlm.nih.gov/28792876/ DOI: 10.1056/nejmoa1616361","model_system":"Four patients from unrelated families; sequencing and circulating metabolites, with parallel enzyme and mouse experiments","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [nia-clin-shi2017] NAD Deficiency, Congenital Malformations, and Niacin Supplementation. (2017). https://pubmed.ncbi.nlm.nih.gov/28792876/ DOI: 10.1056/nejmoa1616361","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"a62b7b5b-786a-57e9-85e9-67c6912a5054","stable_key":"import-a9dd23c6-978a-5755-8bd8-f29bd1fe0cda","title":"Niacin: NAD metabolism, deficiency and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"a8cac59639322f74812ce12eef338c2f6c385c04cc4af6ab511fc7c972f0c2e6","revision_id":"bec8fc45-12e7-5f75-a814-5d72ed015d01","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}